Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
24.72
+0.05 (0.20%)
Sep 4, 2025, 3:43 PM - Market open
Indivior Market Cap
Indivior has a market cap or net worth of $3.08 billion as of September 4, 2025. Its market cap has increased by 83.68% in one year.
Market Cap
3.08B
Enterprise Value
2.97B
1-Year Change
83.68%
Ranking
Category
Stock Price
$24.72
Market Cap Chart
Since December 29, 2014, Indivior's market cap has increased from $1.53B to $3.08B, an increase of 101.51%. That is a compound annual growth rate of 6.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 3.08B | 98.15% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | 1.07B | 182.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 248.96B |
| Novartis AG | 245.38B |
| Abbott Laboratories | 230.89B |